The largest database of trusted experimental protocols

Ultimate 3000 rslc nano chromatograph

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Ultimate 3000 RSLC-Nano chromatograph is a compact, high-performance liquid chromatography system designed for nano-scale separations. It features a robust design, advanced flow path, and high-precision pumps to deliver accurate and reproducible results in a wide range of applications.

Automatically generated - may contain errors

5 protocols using ultimate 3000 rslc nano chromatograph

1

Quantitative Proteomics of STAT3 Modifications

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aliquots of the tryptic digests of STAT3 proteins treated with DMSO (control) and those treated with Stattic and TTI-101 were analyzed by LC-MS/MS on an Ultimate 3000 RSLC-Nano chromatograph interfaced to an Orbitrap Fusion high-resolution mass spectrometer (Thermo Scientific, Waltham MA). All MS/MS data were analyzed using Sequest-HT (Thermo Scientific). Proteins were identified by searching their fragment spectra against the Swiss-Prot protein database (EBI). The iodoacetamide derivative of cysteine, stattic adducts of cysteine, and the predicted TTI-101 adducts of cysteine were specified as variable modifications. To access for potential unknown modifications, the data was analyzed in MaxQuant using the dependent peptide search option [12 (link)]. An all-peptides output list was analyzed by comparing Stattic, TTI-101 and TTI-101ox with DMSO treated samples, as described in [13 ].
+ Open protocol
+ Expand
2

SILAC Protein Identification by Orbitrap

Check if the same lab product or an alternative is used in the 5 most similar protocols
SILAC samples were separated using UltiMate 3000 RSLCnano chromatograph (Thermo Fisher Scientific, Massachusetts, USA). Peptides were loaded on a pre-column (μ-precolumn, 30 mm i.d., 5 mm length, C18 PepMap 100, 5 μm particle size, 100 Å pore size) and further separated on an Acclaim PepMap RSLC column (75 mm i.d., length 500 mm, C18, particle size 2 mm, pore size 100 Å) with a 300 nl/min flow rate using a linear gradient: 2% B over 4 min, 2–40% B over 64 min, 40–98% B over 2 min, with A = 0.1% aq. formic acid and B = 80% AcN in 0.08% aq. formic acid. Peptides eluting from the column were introduced into an Orbitrap Elite (Thermo Fisher Scientific, Massachusetts, USA) operating in Top20 data dependent acquisition mode. A survey scan of 400–2000 m/z was performed in the Orbitrap at 120000 resolution with an AGC target of 1 × 106 and 200 ms injection time followed by twenty data-dependent MS2 scans performed in the LTQ linear ion trap with 1 microscan, 10 ms injection time and 10,000 AGC.
+ Open protocol
+ Expand
3

Quantitative Proteomics by Liquid Chromatography

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tryptic peptides from isotopically labeled cells were separated using an UltiMate 3000 RSLCnano chromatograph (Thermo Fisher Scientific, Waltham, MA, USA). Tryptic peptides were loaded onto a precolumn (μ-precolumn, 30 µm i.d., 5 mm length, C18 PepMap 100, 5 µm particle size, 100 Å pore size) and separated using an Acclaim PepMap RSLC column (75 µm i.d., length 500 mm, C18, particle size 2 µm, pore size 100 Å). Tryptic peptides were separated by a linear gradient of mobile phase B (B = 80% (v/v) acetonitrile (ACN), 0.08% (v/v) formic acid (FA) in water) and A (A = 0.1% (v/v) FA in water) as follows: 2% B over 4 min, 2–40% B over 64 min, and 40–98% B over 2 min. The flow rate was 300 nL/min. Tryptic peptides eluting from the column were injected into an Orbitrap Elite (Thermo Fisher Scientific, Waltham, MA, USA) operating in Top20 data-dependent acquisition mode. Scanning was set to 400–2000 m/z, performed at a 120,000 resolution. The AGC target was 1 × 106 with a 200 ms injection time and twenty data-dependent MS2 scans (1 microscan, 10 ms injection time and 10,000 AGC).
+ Open protocol
+ Expand
4

Quantitative Proteomics of STAT3 Modifications

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aliquots of the tryptic digests of STAT3 proteins treated with DMSO (control) and those treated with Stattic and TTI-101 were analyzed by LC-MS/MS on an Ultimate 3000 RSLC-Nano chromatograph interfaced to an Orbitrap Fusion high-resolution mass spectrometer (Thermo Scientific, Waltham MA). All MS/MS data were analyzed using Sequest-HT (Thermo Scientific). Proteins were identified by searching their fragment spectra against the Swiss-Prot protein database (EBI). The iodoacetamide derivative of cysteine, stattic adducts of cysteine, and the predicted TTI-101 adducts of cysteine were specified as variable modifications. To access for potential unknown modifications, the data was analyzed in MaxQuant using the dependent peptide search option [12 (link)]. An all-peptides output list was analyzed by comparing Stattic, TTI-101 and TTI-101ox with DMSO treated samples, as described in [13 ].
+ Open protocol
+ Expand
5

Glycopeptide Analysis by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC-MS/MS analysis was performed using an Ultimate 3000 RSLCnano chromatograph and Orbitrap Fusion Lumos Mass Spectrometer platform (Thermo) with a multi-nozzle emitter (NEWOMICS, Berkeley, CA, USA) used as the microflow sprayer. Glycopeptide separation was achieved in microflow mode using an Acclaim PepMap 100 capillary column 75 μm ID × 20 mm length, packed with C18 5 μm, 300 Å (Thermo). Glycopeptides were separated as follows: starting condition flow 5 µL, 2% ACN, 0.1% formic acid; 0–1 min flow 5 µL, 2% ACN, 0.1% formic acid; 1–2 min flow 1.5 µL, 2–5% ACN, 0.1% formic acid; 2–5 min flow 1.5 µL, 5–98% ACN, 0.1% formic acid; 7–9 min flow 1.5 µL, 98% ACN, 0.1% formic acid; followed by equilibration to starting conditions for an additional 4 min (Supplementary Figure S1).
We used a Parallel Reaction Monitoring (PRM) workflow with one MS 1 full scan (400–1800 m/z, resolution 120 K, max IT 50 ms) and scheduled MS/MS fragmentation (Isolation window m/z 2.0, HCD fragmentation, resolution 30 K, scan range 200–1400, RF Lens 55%) for the analysis of the sialylated O-HPX glycopeptide TPLPPTSAHGNVAEGETKPDPVTER (Table 1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!